Tetra Bio-Pharma Inc. (TBPMQ)

Market Cap	516.00
Revenue (ttm)	n/a
Net Income	-29.84M
EPS	-0.07
Shares Out	515.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0002
Beta	31.54
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Tetra Bio-Pharma

Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of immunomodulator drugs. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; and REBORN for the treatment of breakthrough cancer pain. It also develops novel prescription drugs and treatments to relieve symptoms associated with advanced cancer pain, chronic pain, Acute Respiratory Distress Syndrome, sepsis and ophthalmic disease. The company is headquartered in Orléans, Canada.

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 33
• Stock Exchange: OTCMKTS
• Ticker Symbol: TBPMQ

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 26, 2026

Data Sources Report a data error